Pediatric Pyelonephritis Workup

  • Author: Robert W Tolan Jr, MD; Chief Editor: Russell W Steele, MD   more...
 
Updated: Feb 9, 2012
 

Approach Considerations

It is prudent to order urinalysis (and urine culture in those with abnormal findings) in all febrile boys younger than 6 months and febrile girls younger than 24 months with fever lasting more than 48 hours. Female adolescents who present with symptoms of UTI, pyelonephritis, and/or vaginitis and who are sexually active must be evaluated for pregnancy and sexually transmitted diseases.

An increased blood urea nitrogen (BUN) and/or creatinine level should raise the suspicion for hydronephrosis or renal parenchymal disease.

Next

Urinalysis

Urine must be collected with proper technique to be useful for diagnosing cystitis or acute pyelonephritis. Suprapubic bladder aspiration should be performed in uncircumcised male patients in whom the urethral meatus is not visible, as well as in infants with periurethral irritation.

Bladder catheterization is the appropriate technique for obtaining a urine sample in most infants and young children. In neonates, suprapubic bladder aspiration may be used. A clean-catch, midstream urine sample may be obtained in children who can cooperate and void on request.

A specimen collected by using sterile bag may be used for urinalysis but not for urine culture. A urine specimen that is positive for nitrite, leukocyte esterase, or blood may indicate UTI. Microscopic examination of an unspun sample that contains more than 10 white blood cells (WBCs) per high-powered field or any bacteria is highly predictive of a positive urine culture. Red blood cell (RBC) or WBC casts suggest underlying renal parenchymal disease. Epithelial cells suggest skin contamination. A normal result from urinalysis does not exclude pyelonephritis.[6]

Previous
Next

Urine Culture

Urine cultures must be obtained in all children with suspected pyelonephritis. Treatment should not be commenced on the basis of urinalysis results, and normal urinalysis findings do not exclude an infection. Acute pyelonephritis may be present even if urine cultures demonstrate no growth.

A clean-catch urine specimen with more than 100,000 colony-forming units (CFUs) of a single organism is considered diagnostic of a UTI. Organisms, such as Lactobacillus, Staphylococcus, or Corynebacterium species, may not be clinically relevant.

Cultures showing more than 100,000 CFUs of a single organism obtained by means of transurethral catheterization are 95% sensitive and 99% specific for UTI. Specimens growing 104 CFUs may be consistent with infection, but the test should be repeated if infection is not likely and if treatment has not yet commenced.

Cultures from bagged urine specimens are useful only if no growth is observed. Bagged urine specimens result in a false-positive rate of 85%. Before treatment is started on the basis of results from a bagged-specimen test, a catheterized or suprapubic specimen should be obtained.

Structural abnormalities of the urinary tract may be associated with infections secondary to multiple organisms or unusual gram-negative bacteria, such as Pseudomonas aeruginosa.

Previous
Next

Electrolyte Measurements

Some patients may have electrolyte abnormalities, which may be secondary to vomiting or diarrhea.

Secondary pseudohypoaldosteronism may develop, with impaired renal tubular function, in infants with pyelonephritis. Mild hyponatremia and hyperkalemia may be present. Infants with underlying urinary-tract anomalies have an increased risk of this electrolyte imbalance, which resolves when the infection is treated.

Previous
Next

Determination of Inflammatory Markers

An elevated WBC count is nonspecific and does not help in distinguishing lower UTI from upper UTI. In the presence of a febrile UTI, however, an erythrocyte sedimentation rate (ESR) of more than 30 mm/h is highly predictive of acute pyelonephritis.

C-reactive protein (CRP) levels are correlated with parenchymal defects on DMSA scanning. Elevated CRP concentrations are sensitive, but nonspecific, markers of renal parenchymal involvement in the febrile infant and child with UTI. CRP values may be used to distinguish bladder colonization from acute pyelonephritis in a febrile child with bacteriuria and a neurogenic bladder.

Procalcitonin is an acute inflammatory marker with a sensitivity of 70-95% and a specificity that approaches 90% for renal involvement in infants and children with febrile UTI. Although less sensitive than CRP, procalcitonin is more specific for the diagnosis of acute pyelonephritis. Procalcitonin values are better correlated with long-term renal scarring than is CRP.[7]

Procalcitonin levels near 0.5 ng/mL may not consistently correlate with acute pyelonephritis. As procalcitonin levels increase, the severity of renal lesions on DMSA increases. Higher levels of procalcitonin predict VUR in infants and children at the onset of pyelonephritis.

Serum and urinary IL-6 and IL-8 are correlated with renal involvement in infants and children with UTI with high sensitivity (81-88%) and acceptable specificity (78-83%). These markers are not reliable in neonates with suspected acute pyelonephritis.

Previous
Next

Radiography

Radiographic studies are generally not indicated to diagnose acute pyelonephritis. Studies may be indicated, however, if the child's condition does not respond to treatment as expected and if colonization must be distinguished from infection in the patient with chronic bacteriuria.

Guidelines from the American Academy of Pediatrics recommend imaging after first febrile UTIs in infants and young children to identify abnormalities that may predispose them to recurrent infection or renal scarring.[8]

Previous
Next

Renal Ultrasonography

In children who have not had ultrasonography performed in the prenatal period, this study may be useful to exclude congenital malformations but is otherwise not helpful in the evaluation of acute pyelonephritis. Renal ultrasonography is useful for determining the size and shape of the kidneys but is generally poor for visualizing nondilated ureters. In addition, it does not provide information regarding renal function.

Renal ultrasonography has low sensitivity (50%) in detecting acute pyelonephritis, although focal abnormalities on ultrasonography, combined with a CRP level of more than 70 mg/L, may be predictive of renal scarring.

Findings on power Doppler ultrasonography have been correlated with DMSA findings of acute pyelonephritis. Renal ultrasonography is useful in the diagnosis of urolithiasis, hydronephrosis, hydroureter, ureteroceles, and bladder distention.[9]

Previous
Next

Voiding Cystourethrography and Nuclear Cystography

VCUG

Voiding cystourethrography (VCUG) is useful for visualizing the urethral and bladder anatomy and for the detecting VUR. Following a second febrile UTI, VCUG may be performed after 3-4 days of therapy to ensure that bladder irritability has resolved and that the urine is sterilized. The voiding phase is needed to evaluate for VUR and posterior urethral valves.

Consistent with new recommendations, VCUG is no longer required as a mandatory part of the evaluation of children with their first febrile urinary tract infection,[10] although it may be of benefit for infants with abnormal 6-month follow-up DMSA scans.[11]

Nuclear cystography

This study is good for evaluating the bladder and detecting VUR. However, it does not permit adequate evaluation of the urethra and is therefore not used for an initial evaluation of the urologic anatomy.

Cystography has only about 1% of the radiation dose of fluoroscopic study. Cystography may be used for serial follow-up studies.

Previous
Next

Nuclear Cortical Scanning

Nuclear cortical scanning depicts tubular damage and scarring. It provides information regarding the general size of the kidneys; however, it does not provide detailed information regarding the collecting system. DMSA scanning is not necessary to evaluate or follow up most episodes of acute pyelonephritis, although DMSA has a sensitivity of more than 90% in detecting changes that are suggestive of acute pyelonephritis. Radiation exposure to the patient undergoing this procedure is low.

This study most frequently involves the use of technetium-99m (99m Tc) DMSA to depict renal cortical scarring. The volume of the initial defect is useful in predicting the development of renal scars.

Follow-up DMSA scans performed more than 6 months after acute pyelonephritis resolves are useful to detect permanent renal scarring. Studies performed less than 6 months after acute pyelonephritis may reveal residua of the original infection rather than permanent scars.

DMSA scans can help in determining the cause of fever in children with chronic bacteriuria, such as patients with spinal-cord injury and those who undergo clean intermittent catheterization.

Previous
Next

Computed Tomography Scanning and Magnetic Resonance Imaging

CT scanning

Enhanced computed tomography (CT) scanning may be useful in distinguishing acute pyelonephritis from other causes of fever. However, increased radiation exposure makes CT scanning a less favorable study in children, especially because ultrasonography is generally adequate in defining the anatomic structure. [#WorkupProcedures]

MRI

Gadolinium-enhanced magnetic resonance imaging (MRI) scans are correlated with DMSA scans in detecting renal parenchymal defects and are effective in distinguishing acute inflammation from scars. MRI is superior to nuclear scintigraphy in distinguishing acute inflammation from chronic scars. MR cystography may be useful in evaluating VUR. Sedation is generally required in MRI.[12, 13]

Previous
 
 
Contributor Information and Disclosures
Author

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: Novartis Honoraria Speaking and teaching

Coauthor(s)

Stephen C Aronoff, MD  Waldo E Nelson Chair and Professor, Department of Pediatrics, Temple University School of Medicine

Stephen C Aronoff, MD is a member of the following medical societies: Pediatric Infectious Diseases Society and Society for Pediatric Research

Disclosure: Nothing to disclose.

Andrea CS McCoy, MD  Associate Professor of Pediatrics, Temple University School of Medicine; Chief Medical Officer, Jeanes Hospital

Andrea CS McCoy, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

Additional Contributors

Leslie L Barton, MD Professor Emerita of Pediatrics, University of Arizona College of Medicine

Leslie L Barton, MD is a member of the following medical societies: American Academy of Pediatrics, Association of Pediatric Program Directors, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

References
  1. Montini G, Tullus K, Hewitt I. Febrile urinary tract infections in children. N Engl J Med. Jul 21 2011;365(3):239-50. [Medline].

  2. Shaikh N, Ewing AL, Bhatnagar S, Hoberman A. Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics. Dec 2010;126(6):1084-91. [Medline].

  3. Lundstedt AC, Leijonhufvud I, Ragnarsdottir B, et al. Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J Infect Dis. Apr 15 2007;195(8):1227-34. [Medline].

  4. Faust WC, Diaz M, Pohl HG. Incidence of post-pyelonephritic renal scarring: a meta-analysis of the dimercapto-succinic acid literature. J Urol. Jan 2009;181(1):290-7; discussion 297-8. [Medline].

  5. Bhat RG, Katy TA, Place FC. Pediatric urinary tract infections. Emerg Med Clin North Am. Aug 2011;29(3):637-53. [Medline].

  6. Williams GJ, Macaskill P, Chan SF, Turner RM, Hodson E, Craig JC. Absolute and relative accuracy of rapid urine tests for urinary tract infection in children: a meta-analysis. Lancet Infect Dis. Apr 2010;10(4):240-50. [Medline].

  7. Pecile P, Romanello C. Procalcitonin and pyelonephritis in children. Curr Opin Infect Dis. Feb 2007;20(1):83-7. [Medline].

  8. American Academy of Pediatrics. Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2 to 24 Months. Pediatrics. Aug 28 2011;[Medline].

  9. Wang YT, Chiu NT, Chen MJ, et al. Correlation of renal ultrasonographic findings with inflammatory volume from dimercaptosuccinic acid renal scans in children with acute pyelonephritis. J Urol. Jan 2005;173(1):190-4; discussion 194. [Medline].

  10. [Guideline] Subcommittee on Urinary Tract Infection; Steering Committe on Quality Improvement and Management. Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2 to 24 Months. Pediatrics. Aug 28 2011;[Medline].

  11. Lee YJ, Lee JH, Park YS. Risk Factors for Renal Scar Formation in Infants With First Episode of Acute Pyelonephritis: A Prospective Clinical Study. J Urol. Jan 18 2012;[Medline].

  12. Kovanlikaya A, Okkay N, Cakmakci H, et al. Comparison of MRI and renal cortical scintigraphy findings in childhood acute pyelonephritis: preliminary experience. Eur J Radiol. Jan 2004;49(1):76-80. [Medline].

  13. Kavanagh EC, Ryan S, Awan A, et al. Can MRI replace DMSA in the detection of renal parenchymal defects in children with urinary tract infections?. Pediatr Radiol. Mar 2005;35(3):275-81. [Medline].

  14. Montini G, Rigon L, Zucchetta P, et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics. Nov 2008;122(5):1064-71. [Medline].

  15. Hodson EM, Willis NS, Craig JC. Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev. Oct 17 2007;CD003772. [Medline].

  16. Williams GJ, Wei L, Lee A, Craig JC. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev. Jul 19 2006;3:CD001534. [Medline].

  17. Garin EH, Olavarria F, Garcia Nieto V, et al. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics. Mar 2006;117(3):626-32. [Medline].

  18. Bloomfield P, Hodson EM, Craig JC. Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev. Jan 25 2005;CD003772. [Medline].

  19. Huang YY, Chen MJ, Chiu NT, Chou HH, Lin KY, Chiou YY. Adjunctive Oral Methylprednisolone in Pediatric Acute Pyelonephritis Alleviates Renal Scarring. Pediatrics. Aug 15 2011;[Medline].

Previous
Next
 
Application of low-risk criteria and approach for the febrile infant: A reasonable approach for treating febrile infants younger than 3 months who have a temperature of greater than 38°C.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.